Vanguard Energy Fund Investors Shares (VGENX) is a good choice for investors who want exposure to th...
Highlights of The San Francisco Money Show
08/10/2008 12:00 am EST
The San Francisco Marriott was the gathering place for thousands of investors who came to hear more than 125 advisors offer their thoughts on the markets and the economy at The San Francisco Money Show.
After watching oil prices skyrocket recently, investors were very anxious to learn whether the professionals intended to buy or sell in the days ahead. Technology-the focus of the show-struck a chord with attendees, who found plenty of offerings of interest, whether in the form of mega trends, or just solid companies piling up profits.
Our keynote speakers enthralled the audience with their take on the upcoming elections, near- and long-term economic forecasts, and their views on domestic vs. global investing.
Investors wandered the exhibit hall, previewing new products, finding out more in-depth information on potential investments and enjoying the opportunity to personally speak with scores of companies.
Dozens of workshops offered strategy tips, market views, and a host of recommendations that attracted investors from both the long and short sides of the markets, as well as those interested primarily in options.
Many of these workshops were Webcast, so if you didn't have the opportunity to join us in San Francisco, we offer you easy access to view what you may have missed. Here in Best of Show, we are featuring the sessions with the highest attendance, for your viewing.
Additionally, we filmed more than 100 interviews in our MoneyShow.com studio. Click here for a taste of what advisors are recommending right now.
And lastly, the advisors at The San Francisco Money Show gave investors hundreds of tips to act on right now. We are pleased to offer you a sampling of their favorite picks.
We hope you enjoy this brief taste of the show and look forward to seeing you at an upcoming event.
Our investing approach — which focuses on higher-rated, higher-yielding, defensively positione...
Pacira Pharmaceuticals (PCRX) recently acquired MyoScience which markets the Iovera system, an FDA a...
Imagine a squadron of battle-ready drones flying alongside U.S. military fighter jets. It’s no...